More than a dozen lawsuits have been filed on behalf of weight-loss drug users who claim that popular weight-loss medications such as Ozempic have caused a loss of vision.
Patients from New York and New Jersey have claimed that they suffered non-arteritic anterior ischemic optic neuropathy after taking drugs containing semaglutide — the active ingredient in Ozempic, Wegovy and Rybelsus. The condition is rare and includes a loss of blood flow to the optic nerve that causes sudden vision loss in one eye.
“People are just waking up and developing this [vision] condition,” Jason Goldstein, the lawyer representing the patients, told Newsday. “They wake and they totally can’t see. A lot of them lose their peripheral vision. They could lose total vision. I have one client who lost it in both eyes.”
